Myriad Asset Management US’s Pfizer PFE Stock Holding History

Myriad Asset Management US’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-59,500	Closed	-$3.12M	–	38
2022 Q2	$3.12M	Buy	+59,500	New	+$3.03M	0.72%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Myriad Asset Management US's PFE Position: Q3 2022 in Review

Myriad Asset Management US sold out of Pfizer (PFE) in Q3 2022, closing a stake of 59,500 shares — an estimated $3.12M sold.

Myriad Asset Management US first reported a position in PFE in Q2 2022 and held it in 1 quarter. The position peaked at $3.12M in Q2 2022. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

Myriad Asset Management US reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
Myriad Asset Management US sold 59,500 Pfizer shares in Q3 2022, an estimated $3.12M.
Myriad Asset Management US first reported a position in Pfizer in Q2 2022 and held it in 1 quarter.
Myriad Asset Management US's Pfizer position peaked at $3.12M in Q2 2022.
3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Myriad Asset Management US's 13F filing for Q3 2022, filed 14 Nov 2022.